Suppr超能文献

人钙调神经磷酸酶以及人FKBP12 - FK506 - 钙调神经磷酸酶复合物的晶体结构。

Crystal structures of human calcineurin and the human FKBP12-FK506-calcineurin complex.

作者信息

Kissinger C R, Parge H E, Knighton D R, Lewis C T, Pelletier L A, Tempczyk A, Kalish V J, Tucker K D, Showalter R E, Moomaw E W

机构信息

Agouron Pharmaceuticals Inc., San Diego, California 92121-1121, USA.

出版信息

Nature. 1995 Dec 7;378(6557):641-4. doi: 10.1038/378641a0.

Abstract

Calcineurin (CaN) is a calcium- and calmodulin-dependent protein serine/threonine phosphate which is critical for several important cellular processes, including T-cell activation. CaN is the target of the immunosuppressive drugs cyclosporin A and FK506, which inhibit CaN after forming complexes with cytoplasmic binding proteins (cyclophilin and FKBP12, respectively). We report here the crystal structures of full-length human CaN at 2.1 A resolution and of the complex of human CaN with FKBP12-FK506 at 3.5 A resolution. In the native CaN structure, an auto-inhibitory element binds at the Zn/Fe-containing active site. The metal-site geometry and active-site water structure suggest a catalytic mechanism involving nucleophilic attack on the substrate phosphate by a metal-activated water molecule. In the FKBP12-FK506-CaN complex, the auto-inhibitory element is displaced from the active site. The site of binding of FKBP12-FK506 appears to be shared by other non-competitive inhibitors of calcineurin, including a natural anchoring protein.

摘要

钙调神经磷酸酶(CaN)是一种钙和钙调蛋白依赖性蛋白丝氨酸/苏氨酸磷酸酶,对包括T细胞活化在内的几个重要细胞过程至关重要。CaN是免疫抑制药物环孢素A和FK506的作用靶点,这两种药物分别与细胞质结合蛋白(亲环蛋白和FKBP12)形成复合物后抑制CaN。我们在此报告了分辨率为2.1埃的全长人CaN晶体结构以及分辨率为3.5埃的人CaN与FKBP12 - FK506复合物的晶体结构。在天然CaN结构中,一个自抑制元件结合在含锌/铁的活性位点。金属位点几何结构和活性位点水结构表明了一种催化机制,即金属激活的水分子对底物磷酸进行亲核攻击。在FKBP12 - FK506 - CaN复合物中,自抑制元件从活性位点移位。FKBP12 - FK506的结合位点似乎与钙调神经磷酸酶的其他非竞争性抑制剂(包括一种天然锚定蛋白)共用。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验